Similar Papers

Paper Title
Journal
Date
Author
Reply to "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis" by Messori et al.
Albert Farrugia ... Megha Bansal
Blood transfusion = Trasfusione del sangue | VOL. 17
Albert Farrugia, et. al.Albert Farrugia ... Megha Bansal
03 Oct 2017
Molecular Genetics of Hemophilia A
...
Journal of Genetics and Molecular Biology | VOL. 6
, et. al. ...
01 Sep 1995
Clinical, Laboratory and Molecular Characterization of Factor VII, Factor X and Their Combined Deficiencies in a Tertiary Care Center
Bereczky Zsuzsanna ... Csongor Kiss
Blood | VOL. 134
Bereczky Zsuzsanna, et. al.Bereczky Zsuzsanna ... Csongor Kiss
13 Nov 2019
Measurement of alloantibodies against FVIII in patients with hemophilia A using a newly-developed ELISA and its clinical application
...
Chinese Journal of Laboratory Medicine | VOL. 33
, et. al. ...
11 Oct 2010
View more papers

More From: Blood Transfusion

Paper Title
Journal
Date
Author
Haemostatic responsiveness and release of biological response modifiers following cryopreservation of platelets treated with amotosalen and ultraviolet A light.
Nahreen Tynngård ... Per Sandgren
Blood Transfusion | VOL. 18
Nahreen Tynngård, et. al.Nahreen Tynngård ... Per Sandgren
04 Jul 2019
Further comments on "High-titre inhibitors in previously untreated patients with severe haemophilia A receiving recombinant or plasma-derived factor VIII: a budget-impact analysis".
Andrea Messori ... Pier Mannuccio Mannucci
Blood Transfusion | VOL. 17
Andrea Messori, et. al.Andrea Messori ... Pier Mannuccio Mannucci
22 Dec 2017
Pathogen inactivated platelets and prevention of immunological adverse reactions: The Italian platelet technology assessment study (IPTAS)
...
Blood Transfusion | VOL. 7
, et. al. ...
19 Mar 2016
Blood Transfusion: the seventh Editor-in-Chief
Blood Transfusion | VOL. 13
01 Apr 2015
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.